Effects of parathyroidectomy on lead mobilization from bone in patients with primary hyperparathyroidism

被引:18
|
作者
Osterode, W
Winker, R
Bieglmayer, C
Vierhapper, H
机构
[1] Univ Vienna, Klin Innere Med 4, Klin Abt Arbeitsmed, A-1090 Vienna, Austria
[2] Univ Vienna, Innere Med Klin 3, Klin Abt Endokrinol & Stoffwechsel, Vienna, Austria
关键词
hyperparathyroidism; lead metabolism; cross-linked telopeptide; osteocalcin; parathyroid hormone;
D O I
10.1016/j.bone.2004.05.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since lead (Pb) accrued from environmental exposure accumulates in bone with a half life time between 6 and 10 years, a release of bone Pb into the circulation and/or urine (PbU) should be expected in diseases with increased bone metabolism such as hyperparathyroidism. We studied 60 patients with primary hyperparathyroidism (pHPT, 50 women, 10 men, aged 61.4 +/- 10.6 and 64.1 +/- 9.9 years, respectively) (a) before, (b) 1-6 months, and (c) 6-12 months after parathyroidectomy. Besides lead in blood (PbB) and lead in 24-h urine samples (PbU), parathyroid hormone (PTH), serum Ca2+, osteocalcin (OC), phosphate (PO4), and serum pyridinoline cross-linked telopeptide (cTP) were determined. Control data were determined in 20 healthy age-matched subjects. As expected, Ca2+ decreased after parathyroidectomy. Mean PbB in patients with pHPT was in the same range as in controls. A decrease of PbB after parathyroidectomy was found in the interval beyond 6 months. In contrast, mean PbU initially increased after surgery (3.05 +/- 1.94 vs. 4.25 +/- 2.65 mug/l, P = 0.004) and was not different beyond 6 months in comparison with preoperative values at (c). Investigating only patients with PTH < 150 ng/l, no significant PbB or PbU alterations were detected before and after parathyroidectomy. In patients with PTH > 150 ng/l, the decrease of PbB at (c) was more pronounced as was the increase of PbU at (b). In these patients, PbB and OC as well as PbB and cTP were correlated preoperatively. In conclusion, our data show that in environmentally lead-exposed (by food or by pollution) hyperparathyroid individuals, there is no hazardous PbB release from bone. The preoperative correlation between PbB and OC in pHPT patients with PTH > 150 ng/l provides evidence that in fact there is a Pb release from bone into the blood-pool by bone remodeling. The increase of PbU after parathyroidectomy is suspected to be caused by PTH-dependent Pb accumulation in the kidney, which seems to be restored with decreasing PTH. Moreover, our data confirm prior findings that bone remodeling seems to be normalized 6 months after parathyroidectomy. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:942 / 947
页数:6
相关论文
共 50 条
  • [1] The effect of parathyroidectomy on bone mineral density in primary hyperparathyroidism
    Caliskan, Mustafa
    Beysel, Selvihan
    Kizilgul, Muhammed
    Ozbek, Mustafa
    Cakal, Erman
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (06) : 1674 - 1680
  • [2] Forestalling Hungry Bone Syndrome after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism
    Carsote, Mara
    Nistor, Claudiu
    DIAGNOSTICS, 2023, 13 (11)
  • [3] Serum Klotho levels in primary hyperparathyroidism patients before and after parathyroidectomy
    Chi Su
    Lingqiong Meng
    Stanley Z. Trooskin
    Sue A. Shapses
    Yuling He
    Aseel Al-Dayyeni
    Xiangbing Wang
    Endocrine, 2020, 70 : 421 - 425
  • [4] Serum Klotho levels in primary hyperparathyroidism patients before and after parathyroidectomy
    Su, Chi
    Meng, Lingqiong
    Trooskin, Stanley Z.
    Shapses, Sue A.
    He, Yuling
    Al-Dayyeni, Aseel
    Wang, Xiangbing
    ENDOCRINE, 2020, 70 (02) : 421 - 425
  • [5] Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?
    Emanuela Traini
    Rocco Bellantone
    Serena Elisa Tempera
    Salvatore Russo
    Carmela De Crea
    Celestino Pio Lombardi
    Marco Raffaelli
    Langenbeck's Archives of Surgery, 2018, 403 : 317 - 323
  • [6] Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?
    Traini, Emanuela
    Bellantone, Rocco
    Tempera, Serena Elisa
    Russo, Salvatore
    De Crea, Carmela
    Lombardi, Celestino Pio
    Raffaelli, Marco
    LANGENBECKS ARCHIVES OF SURGERY, 2018, 403 (03) : 317 - 323
  • [7] Effect of Hypoalbuminemia in Patients Undergoing Parathyroidectomy for Primary Hyperparathyroidism
    Khawaja, Imran M.
    Randhawa, Avneet
    Randhawa, Karandeep
    Aftab, Owais M.
    Patel, Roshan V.
    Eloy, Jean Anderson
    Fang, Christina H.
    LARYNGOSCOPE, 2023, 133 (08): : 2035 - 2039
  • [8] Trabecular Bone Score, Bone Mineral Density and Bone Markers in Patients with Primary Hyperparathyroidism 2 Years After Parathyroidectomy
    Allo Miguel, Gonzalo
    Hawkins Carranza, Federico
    Romero Rodriguez, Juan Carlos
    Aramendi Ramos, Mercedes
    Lora Pablos, David
    Ferrero Herrero, Eduardo
    Martinez Diaz-Guerra, Guillermo
    HORMONE AND METABOLIC RESEARCH, 2019, 51 (03) : 186 - 190
  • [9] Bisphosphonates can reduce bone hunger after parathyroidectomy in patients with primary hyperparathyroidism and osteitis fibrosa cystica
    Pinto Toscano de Franca, Tatiana Clementino
    Griz, Luiz
    Pinho, Jorge
    Diniz, Erik Trovao
    de Andrade, Luena Dias
    Lucena, Cynthia Salgado
    Beserra, Susyane Ribeiro
    Jorge Asano, Nadja Maria
    Duarte, Angela Pinto
    Bandeira, Francisco
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2011, 51 (02) : 124 - 137
  • [10] MINIMALLY INVASIVE PARATHYROIDECTOMY FOR PRIMARY HYPERPARATHYROIDISM
    Urkan, M.
    Peker, Y. S.
    Ozturk, E.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2019, 15 (02) : 182 - 186